SCHEMBL9701074

SCHEMBL9701074

O=C(Cl)OC1(OC(=O)Cl)CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362279 0.86 NPSR1 (0.32)
SCHEMBL11249738 0.83 NPSR1 (0.33)
SCHEMBL11254069 0.78 NPSR1 (0.31)
SCHEMBL6679592 0.76 CYP2C19 (0.36) CYP2C19
SCHEMBL318859 0.75 CYP19A1 (0.42)
SCHEMBL1326935 0.74 ALDH1A1 (0.32) CYP2C19
SCHEMBL7057969 0.72 CYP2C19 (0.32) CYP2C19
SCHEMBL10702855 0.72 CYP19A1 (0.40)
SCHEMBL3638544 0.70 ALDH1A1 (0.33)
SCHEMBL10927098 0.70 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4999417-A Drug carriers for controlled release NOVA PHARMACEUTICAL CORPORATION (US) 1991-03-12 US claimed
EP-0483429-A1 Biodegradable polymer compositions NOVA PHARMACEUTICAL CORPORATION (US) 1992-05-06 EP disclosed
US-4999417-A Drug carriers for controlled release NOVA PHARMACEUTICAL CORPORATION (US) 1991-03-12 US disclosed